Luke Selth

20PUBLICATIONS

114CO-AUTHORS

Molecular targetsPredictive and prognostic markersCancer diagnosisMedical molecular engineering of nucleic acids and proteinsCell and nuclear division

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (20)

Sort by Publication Date:

|Jun 02, 2026

USP2 is an androgen-repressed survival factor that stabilises oncoproteins to facilitate therapy resistance in prostate cancer.

|Mar 25, 2026

Single-Cell and Spatial Transcriptomic Profiling Reveals Epithelial Functional States and Fibroblast Phenotypes in Hormone Therapy-Naïve Localized Prostate Cancer.

Eva Apostolov, Daniel L Roden, Holly Holliday

|Oct 14, 2025

Protein disulfide isomerases regulate androgen receptor stability and promote prostate cancer cell growth and survival.

Jianling Xie, Kaikai Shen, Wenken Liang

|Nov 08, 2024

Friend or foe? Deciphering androgen receptor action to improve bipolar androgen therapy for prostate cancer.

Samuel P G Rollin, Mitchell G Lawrence, Anthony M Joshua

|Oct 25, 2024

Author Correction: CDK9 inhibition constrains multiple oncogenic transcriptional and epigenetic pathways in prostate cancer.

Razia Rahman, Muhammed H Rahaman, Adrienne R Hanson

|Aug 08, 2024

CDK9 inhibition inhibits multiple oncogenic transcriptional and epigenetic pathways in prostate cancer.

Razia Rahman, Muhammed H Rahaman, Adrienne R Hanson

Pageof 4

Frequent Collaborators

10 joint publications

Lisa M Butler

Wayne Tilley

Jianling Xie

Zeyad D Nassar

Simon J Conn

Gail P Risbridger

Raj Shrestha

Chui Yan Mah

Matthew J Watt

Johannes V Swinnen

Frequent Collaborators

10 joint publications

Lisa M Butler

8 joint publications

Wayne Tilley

5 joint publications

Jianling Xie

4 joint publications

Zeyad D Nassar